This 13-page scientific report describes the NICHD's plan to support research on the basic biological science necessary to understand early development in utero through the time when many organ systems form. The information in this plan was current at the date of publication, but has not been updated. The document is provided for historical purposes only.

This 37-page scientific report describes the overall plan for many of the NICHD's scientific initiatives. The plan focuses on areas of major scientific opportunities, including developmental biology, biobehavioral development, reproductive health, genetics of disease susceptibility, and sudden infant death syndrome (SIDS), and outlines research technologies and resources and education and training related to these topics. The information in this report was current at the date of publication, but has not been updated. The document is provided for historical purposes only.

This 43-page scientific report describes the NICHD's overall plan to support research that addresses health disparities, specifically in the areas of infant and maternal mortality and morbidity; reproductive health; HIV/AIDS in women and teens; early antecedents of disparities in disease and growth; early antecedents of child well being and adverse behaviors; school readiness, cognitive and behavioral development; restoring function and preventing disability, training and career development, and outreach to communities and their institutions. The information in this plan was current at the date of publication, but has not been updated. The document is provided for historical purposes only.

This fact sheet describes the NICHD's Human Placenta Project, a research effort aimed at understanding the placenta. The Project aims to develop tools and methods to safely study the placenta in real-time to learn more about this link between mother and fetus. Findings from the Human Placenta Project could enable health care providers to fix problems with the placenta before they negatively affect a pregnancy.

This 1-page handout lists NICHD extramural branches and centers that fund neuroscience research, describes areas of research each supports, and provides contact information.

This 48-page report outlines research directions and priorities for NICHD for the next 5 years. Research themes include: understanding the molecular, cellular, and structural basis of development; promoting gynecologic, andrologic, and reproductive health; setting the foundation for healthy pregnancies and lifelong wellness; improving child and adolescent health and the transition to adulthood; and advancing safe and effective therapeutics and devices for pregnant and lactating women, children, and people with disabilities. The plan also include cross-cutting themes, aspirational goals, and scientific stewardship activities. This document is provided for reference only. It is no longer being updated.

The NICHD Strategic Plan 2025 builds upon the institute's 2020 plan to outline scientific research goals and objectives for the next five years. The 52-page plan includes five broad scientific goals, multiple cross-cutting themes, aspirational goals, and activities to address capacity building, scientific stewardship, management, and accountability. It also features scientific images from research conducted and supported by NICHD. 

This 95-page scientific plan outlines research goals and objectives on Fragile X syndrome and related disorders for the NIH Institutes, including the NICHD, which support and conduct research related to Fragile X syndrome and its associated disorders. The plan was developed by the NIH Fragile X Research Coordinating Group, which includes representatives from multiple NIH Institutes, Centers, and Offices and relevant scientific, family, and advocacy communities. The information in this publication was accurate at the time it was published, but it is not being updated. The publication is provided for historical purposes only.

This 32-page research plan lays out a scientific agenda for the NIH to conduct and gather rigorous scientific evidence needed to answer questions and fill in knowledge gaps about vulvodynia, as of 2012. The agenda builds upon ongoing vulvodynia research (supported by the NICHD, NIH, and other agencies and organizations) and aims to advance the field by enhancing capacity for conducting research related to vulvodynia. Please note that the information is no longer current and is for reference only. For this reason, this publication is available online only.

This 44-page plan identifies priorities for NIH research activities on three conditions known to be associated with the FMR1 gene: Fragile X syndrome, Fragile X-associated Tremor and Ataxia Syndrome, and Fragile X-associated Primary Ovarian Insufficiency. It also describes research directions on the FMR1 gene itself, mutations that affect the gene’s function, and the role of the FMR1 protein in the development and progression of these conditions. It was developed over several years and incorporates input from scientists, healthcare providers, and support organizations with an interest in FMR1-related conditions, as well as families and individuals affected by the conditions.